Cytotoxic sensitivity to tumor necrosis factor-α in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)

Prostate

Volumn 39, Issue 2, 1999, Pages 87-93

  Sintich, Sharon M ^a   Steinberg, Joseph ^a   Kozlowski, James M ^a   Lee, Chung ^a   Pruden, Shaina ^a   Sayeed, Sakina ^a   Sensibar, Julia A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Clusterin; Cytotoxicity; Prostate cancer; SGP 2; Tumor necrosis factor

Indexed keywords

ANTIBODY; CLUSTERIN; GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ASSAY; CELL COUNT; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TARGET CELL; TUMOR CELL LINE;

CELL DEATH; CLUSTERIN; GLYCOPROTEINS; HUMANS; MALE; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033119232     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990501)39:2<87::AID-PROS2>3.0.CO;2-Z     Document Type: Article

References (24)

1. Fritz IB, Burdzy C, Setchell B, Blaschuk O. Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol Reprod 1983;28:1173-1188.
2. Bettuzzi S, Hiipakka RA, Gilna P, Liao S. Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulfated glycoprotein-2 by cDNA cloning and sequence analysis. Biochem J 1989;257:293-296.
3. Lee C, Sensibar J. Proteins of the rat prostate. II. Synthesis of new proteins in the ventral lobe during castration-induced regression. J Urol 1987;138:903-908.
4. Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein-2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 1989;86: 7123-7127.
5. Sylvester SR, Morales C, Oko R, Griswold M. Localization of sulfated glycoprotein-2 (clusterin) on spermatozoa and in the reproductive tract of the male rat. Biol Reprod 1991;45:195-207.
6. Jordan-Stark TC, Witte DP, Aronow BJ, Harmony JAK. Apolipoprotein J: a membrane policeman. Curr Opin Lipidol 1992;3: 75-85.
7. Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by over-expression of sulfated glycoprotein-2 (clusterin). Cancer Res 1995;55:2431-2437.
8. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyck M, Ng P-Y, Sawczuk I. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 1989;9:3473-3481.
9. Duguid JR, Bohmont N, Liu N, Tourtellotte WW. Changes in brain gene expression shared by scrapie and Alzheimer's disease. Proc Natl Acad Sci USA 1989;86:7260-7264.
10. Kyprianou N, English HF, Isaacs JT. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 1990;50:3748-3753.
11. Pasientti GM, Finch CE. Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci Lett 1991;130:1-4.
12. Sherwood E, Ford T, Lee C, Kozlowski J. Therapeutic efficacy of recombinant tumor necrosis factor a in an experimental model of human prostatic carcinoma. J Biol Response Mod 1990;9:44-52.
13. Bradford MA. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 1976;72:248-251.
14. 4. Nature 1970;227:680-685.
15. Rokhin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57:1758-1768.
16. Steinberg J, Oyasu R, Lang S, Rademaker A, Lee C, Kozlowski JM, Sensibar JA. Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 1997; 3:1707-1711.
17. Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931.
18. Opipari AW, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992;267:12424-12427.
19. Jaattela M, Benedict M, Shayman JA, Dixit VM. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 1995;10:2297-2305.
20. Cai Z, Capoulade C, Moyret-Lalle C, Amor-Gueret M, Feunteun J, Larsen AK, Bressac-de Paillerets B, Chouaib S. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene 1997;15:2817-2826.
21. Sensibar JA, Qian Y, Griswold MD, Sylvester SR, Bardin CW, Cheng CY, Lee C. Localization and molecular heterogeneity of sulfated glycoprotein-2 (clusterin) among ventral prostate, seminal vesicle, testis, and epididymis of rats. Biol Reprod 1994; 49:233-242.
22. French LE, Sappino AP, Tschopp J, Schifferli JA. Distinct sites of production and deposition of the putative cell death marker clusterin in human thymus. J Clin Invest 1992;90:1919-1925.
23. Yanaga F, Watson SP. Tumor necrosis factor a stimulates sphingomyelinase through the 55 KDa receptor in HL-60 cells. FEBS Lett 1992;314:297-300.
24. Kolesnick RN, Haimovitz-Friedman A, Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 1994;72:471-474.